David Rescott
Stock Analyst at Baird
(3.80)
# 757
Out of 4,734 analysts
42
Total ratings
54.29%
Success rate
9.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NARI Inari Medical | Downgrades: Neutral | $81 → $80 | $79.55 | +0.57% | 4 | Jan 7, 2025 | |
| MDT Medtronic | Maintains: Neutral | $96 → $93 | $88.08 | +5.59% | 3 | Nov 20, 2024 | |
| PEN Penumbra | Maintains: Outperform | $244 → $248 | $263.69 | -5.95% | 16 | Oct 31, 2024 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $107 → $109 | $102.90 | +5.93% | 2 | Oct 31, 2024 | |
| LIVN LivaNova | Maintains: Outperform | $66 → $72 | $48.30 | +49.07% | 3 | Oct 31, 2024 | |
| EW Edwards Lifesciences | Maintains: Neutral | $73 → $68 | $69.78 | -2.55% | 3 | Oct 25, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $503 → $565 | $592.64 | -4.66% | 1 | Oct 18, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $90 → $91 | $98.66 | -7.76% | 4 | Jul 25, 2024 | |
| SIBN SI-BONE | Maintains: Buy | $25 → $26 | $16.69 | +55.78% | 6 | Dec 22, 2023 |
Inari Medical
Jan 7, 2025
Downgrades: Neutral
Price Target: $81 → $80
Current: $79.55
Upside: +0.57%
Medtronic
Nov 20, 2024
Maintains: Neutral
Price Target: $96 → $93
Current: $88.08
Upside: +5.59%
Penumbra
Oct 31, 2024
Maintains: Outperform
Price Target: $244 → $248
Current: $263.69
Upside: -5.95%
Merit Medical Systems
Oct 31, 2024
Maintains: Outperform
Price Target: $107 → $109
Current: $102.90
Upside: +5.93%
LivaNova
Oct 31, 2024
Maintains: Outperform
Price Target: $66 → $72
Current: $48.30
Upside: +49.07%
Edwards Lifesciences
Oct 25, 2024
Maintains: Neutral
Price Target: $73 → $68
Current: $69.78
Upside: -2.55%
Intuitive Surgical
Oct 18, 2024
Maintains: Outperform
Price Target: $503 → $565
Current: $592.64
Upside: -4.66%
Boston Scientific
Jul 25, 2024
Maintains: Outperform
Price Target: $90 → $91
Current: $98.66
Upside: -7.76%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25 → $26
Current: $16.69
Upside: +55.78%